# EDGAR Filing Document

**Accession Number:** 0001996862
**File Stem:** 0001996862-25-000201
**Filing Date:** 2025-7
**Character Count:** 59742
**Document Hash:** 1f819975ed94640a4f177dfa7afceff8
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001996862-25-000201.hdr.sgml**: 20250730

**ACCESSION NUMBER**: 0001996862-25-000201

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 15

**CONFORMED PERIOD OF REPORT**: 20250730

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20250730

**DATE AS OF CHANGE**: 20250730

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Bunge Global SA
- **CENTRAL INDEX KEY:** 0001996862
- **STANDARD INDUSTRIAL CLASSIFICATION:** FATS & OILS [2070]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 000000000
- **STATE OF INCORPORATION:** V8
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-56607
- **FILM NUMBER:** 251163853

**BUSINESS ADDRESS:**
- **STREET 1:** ROUTE DE FLORISSANT 13
- **CITY:** GENEVA
- **STATE:** V8
- **ZIP:** 1206
- **BUSINESS PHONE:** 41 22 592 91 00

**MAIL ADDRESS:**
- **STREET 1:** ROUTE DE FLORISSANT 13
- **CITY:** GENEVA
- **STATE:** V8
- **ZIP:** 1206

?xml version='1.0' encoding='ASCII'? bg-20250730

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**___________________________________**

**FORM 8-K**

**___________________________________**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**July 30, 2025**

Date of Report (date of earliest event reported)

**___________________________________**

**BUNGE GLOBAL SA**

(Exact name of registrant as specified in its charter)

**___________________________________**

**Switzerland**<br>(State of Incorporation)<br>

---

| | |
|:---|:---|
| **000-56607**<br>(Commission File Number) | **98-1743397**<br>(IRS Employer Identification Number) |
| **Route de Florissant 13,**<br>**1206 Geneva, Switzerland** | **N.A** |
| (Address of principal executive offices and zip code) | (Zip Code) |
| **1391 Timberlake Manor Parkway**<br>**Chesterfield, MO** | **63017** |
| (Address of corporate headquarters) | (Zip Code) |
| **(314) 292-2000** | **(314) 292-2000** |
| (Registrant's telephone number, including area code) | (Registrant's telephone number, including area code) |
| **N/A** | **N/A** |
| (Former name or former address, if changed since last report) | (Former name or former address, if changed since last report) |

---

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

**☐** Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

**☐** Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

**☐** Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

**☐** Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

---

| | | |
|:---|:---|:---|
| **Securities registered pursuant to Section 12(b) of the Act:** | **Securities registered pursuant to Section 12(b) of the Act:** | **Securities registered pursuant to Section 12(b) of the Act:** |
| **<u>Title of each class</u>** | **<u>Trading Symbol</u>** | **<u>Name of each exchange on which registered</u>** |
| **Registered Shares, $0.01 par value per share** | **BG** | **New York Stock Exchange** |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company&nbsp;&nbsp;&nbsp;&nbsp;☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 2.02 Results of Operations and Financial Condition &nbsp;&nbsp;&nbsp;&nbsp;** 

On July 30, 2025, Bunge Global SA ("Bunge") issued a press release announcing its financial results for the three and six months ended June 30, 2025. The press release is furnished as Exhibit 99.1 to this report and incorporated herein by reference.

In accordance with general instruction B.2 of Form 8-K, the information in this Item 2.02, including exhibits, is furnished pursuant to Items 2.02 and 9.01 and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that section.

**Item 9.01 Financial Statements and Exhibits**

(d): &nbsp;&nbsp;&nbsp;&nbsp;Exhibits.

---

| | |
|:---|:---|
| <u>Exhibit No.</u> | <u>Description</u> |
| <u>[99.1](epr06302025.htm)</u> | Press Release, dated July 30, 2025 |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

------

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: July 30, 2025

---

| | |
|:---|:---|
| **BUNGE GLOBAL SA** | **BUNGE GLOBAL SA** |
| By: | /s/John W. Neppl |
| Name: | John W. Neppl |
| Title: | Executive Vice President, Chief Financial Officer |

---

## Exhibit 99.1

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

![bunge-rgb1a.jpg](bunge-rgb1a.jpg)

**Bunge Reports Second Quarter 2025 Results&nbsp;&nbsp;&nbsp;&nbsp;**

**St. Louis, MO - July 30, 2025 - Bunge Global SA (NYSE: BG) today reported second quarter 2025 results**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**• Q2 GAAP diluted EPS of $2.61 vs. $0.48 in the prior year; $1.31 vs. $1.73 on an adjusted basis excluding certain gains/charges and mark-to-market timing differences** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**• Agribusiness results better than expected driven by Processing, though down from last year**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**• Refined and Specialty Oils results reflected lower energy demand due to policy uncertainty**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**• Recently completed merger with Viterra to create premier global agribusiness solutions company; integration well underway**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**• Completed sale of US corn milling furthering business alignment with global value chains**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**• Maintaining adjusted full-year EPS outlook of approximately $7.75** 

---

| | |
|:---|:---|
| ⮚ | **Overview** |

---

Greg Heckman, Bunge's Chief Executive Officer, commented, "Our team delivered better than expected results for the second quarter given market conditions while also making significant progress on our strategic priorities. Most notably, we completed our transformative combination with Viterra. The integration is proceeding well, and we are pleased to begin working aggressively on commercial opportunities. We also completed the sale of our U.S. corn milling business which further simplifies our portfolio along our global integrated value chains.

"With our increased diversity across crops and geographies, we are even better positioned to efficiently connect farmers to consumers and deliver essential food, feed and fuel to the world. I am confident that our enhanced scale and capabilities will allow us to meet the evolving needs of our customers and deliver greater value to all our stakeholders as we move forward."

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| ⮚ | **Financial Highlights** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>June 30,** | **Three Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** |
|<br>**(US$ in millions, except per share data)** | **2025** | **2024** | **2025** | **2024** |
| **Net income attributable to Bunge** | $**354** | $**70** | $**555** | $**314** |
| **Net income per share-diluted** | $**2.61** | $**0.48** | $**4.10** | $**2.17** |
| Mark-to-market timing differences <sup>(a)</sup> | $(0.69) | $0.82 | $(0.62) | $1.75 |
| Certain (gains) & charges <sup>(b)</sup> | $(0.61) | $0.43 | $(0.36) | $0.85 |
| **Adjusted Net income per share-diluted** <sup>(c)</sup> | $**1.31** | $**1.73** | $**3.12** | $**4.77** |
| **Segment EBIT** <sup>(c) (d)</sup> | $**659** | $**361** | $**1063** | $**898** |
| &nbsp;&nbsp;&nbsp;&nbsp;Mark-to-market timing differences <sup>(a)</sup> | (128) | 158 | (126) | 340 |
| &nbsp;&nbsp;&nbsp;&nbsp;Certain (gains) & charges <sup>(b)</sup> | (155) |  | (155) |  |
| **Adjusted Segment EBIT** <sup>(c)</sup> | $**376** | $**519** | $**782** | $**1238** |
| **Corporate and Other EBIT** <sup>(c)(e)</sup> | $**(121)** | $**(176)** | $**(197)** | $**(280)** |
| &nbsp;&nbsp;&nbsp;&nbsp;Certain (gains) & charges <sup>(b)</sup> | 38 | 62 | 70 | 123 |
| **Adjusted Corporate and Other EBIT** <sup>(c)</sup> | $**(83)** | $**(114)** | $**(127)** | $**(157)** |
| **Total EBIT** <sup>(c)</sup> | $**538** | $**185** | $**866** | $**618** |
| &nbsp;&nbsp;&nbsp;&nbsp;Mark-to-market timing differences <sup>(a)</sup> | (128) | 158 | (126) | 340 |
| &nbsp;&nbsp;&nbsp;&nbsp;Certain (gains) & charges <sup>(b)</sup> | (117) | 62 | (85) | 123 |
| **Adjusted Total EBIT** <sup>(c)</sup> | $**293** | $**405** | $**655** | $**1081** |

---

*(a)Mark-to-market timing impact of certain commodity and freight contracts, readily marketable inventories ("RMI"), and related hedges associated with committed future operating capacity and sales. See note 3 in the Additional Financial Information section of this release for details.* 

*(b)Certain (gains) & charges included in Total earnings before interest and tax ("EBIT") and Net income attributable to Bunge. See Additional Financial Information for details.* 

*(c)Segment earnings before interest and tax ("Segment EBIT"), Adjusted Segment EBIT, Corporate and Other EBIT, Adjusted Corporate and Other EBIT, Total EBIT, Adjusted Total EBIT, and Adjusted Net income per share-diluted are non-GAAP financial measures. Reconciliations to the most directly comparable U.S. GAAP measures are included in the tables attached to this press release and the accompanying slide presentation posted on Bunge's website.* 

*(d)Segment EBIT comprises the aggregate EBIT of Bunge's Agribusiness, Refined and Specialty Oils and Milling reportable segments, and excludes Corporate and Other activities.*

*(e)Corporate and Other includes salaries and overhead for corporate functions, including acquisition and integration costs related to the Viterra Acquisition, that are not allocated to the Company's individual reporting segments, as well as certain other activities including Bunge Ventures, the Company's captive insurance activities, and accounts receivable securitization activities. Corporate and Other also includes historical results of Bunge's previously recognized Sugar & Bioenergy segment. See note 6 in the Additional Financial information section of this release for details.*

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| ⮚ | **Second Quarter Results** |

---

**Reportable Segments**

**Agribusiness**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
|<br>**(US$ in millions)** | **Jun 30, 2025** | **Jun 30, 2024** | **Jun 30, 2025** | **Jun 30, 2024** |
| **Volumes (in thousand metric tons)** | **19274** | **20579** | **37551** | **40771** |
| **Net Sales** | $**9167** | $**9657** | $**17328** | $**19397** |
| **Gross Profit** | $**471** | $**289** | $**774** | $**743** |
| **Selling, general and administrative expense** | $**(141)** | $**(150)** | $**(276)** | $**(305)** |
| **Foreign exchange gains (losses) – net** | $**33** | $**(39)** | $**62** | $**(101)** |
| **EBIT attributable to noncontrolling interests** | $**(13)** | $**7** | $**(11)** | $**10** |
| **Other income (expense) - net** | $**28** | $**56** | $**90** | $**109** |
| **Income (loss) from affiliates** | $**3** | $**(25)** | $**12** | $**(40)** |
| **Segment EBIT** | $**381** | $**138** | $**651** | $**416** |
| &nbsp;&nbsp;&nbsp;&nbsp;Mark-to-market timing differences | (148) | 160 | (150) | 369 |
| &nbsp;&nbsp;&nbsp;&nbsp;Certain (gains) & charges |  |  |  |  |
| **Adjusted Segment EBIT** | $**233** | $**298** | $**501** | $**785** |

---

***Processing*** <sup>(2)</sup>

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
|<br>**(US$ in millions)** | **Jun 30, 2025** | **Jun 30, 2024** | **Jun 30, 2025** | **Jun 30, 2024** |
| Processing EBIT  | $361 | $122 | $594 | $302 |
| &nbsp;&nbsp;&nbsp;&nbsp;Mark-to-market timing differences | (155) | 143 | (181) | 374 |
| &nbsp;&nbsp;&nbsp; Certain (gains) & charges |  |  |  |  |
| Adjusted Processing EBIT | $206 | $265 | $413 | $676 |

---

Higher results in South America and Asia were more than offset by lower results in Europe and North America.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

***Merchandising*** <sup>(2)</sup>

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
|<br>**(US$ in millions)** | **Jun 30, 2025** | **Jun 30, 2024** | **Jun 30, 2025** | **Jun 30, 2024** |
| Merchandising EBIT  | $20 | $16 | $57 | $114 |
| &nbsp;&nbsp;&nbsp;&nbsp;Mark-to-market timing differences | 7 | 17 | 31 | (5) |
| &nbsp;&nbsp;&nbsp; Certain (gains) & charges |  |  |  |  |
| Adjusted Merchandising EBIT | $27 | $33 | $88 | $109 |

---

Improved performance in global grains and oils were more than offset by lower results in our financial services and ocean freight businesses.

**Refined & Specialty Oils**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
|<br>**(US$ in millions)** | **Jun 30, 2025** | **Jun 30, 2024** | **Jun 30, 2025** | **Jun 30, 2024** |
| **Volumes (in thousand metric tons)** | **2175** | **2300** | **4305** | **4495** |
| **Net Sales** | $**3177** | $**3121** | $**6269** | $**6361** |
| **Gross Profit** | $**225** | $**315** | $**462** | $**674** |
| **Selling, general and administrative expense** | $**(107)** | $**(100)** | $**(207)** | $**(200)** |
| **Foreign exchange gains (losses) – net** | $**(3)** | $**(2)** | $**(7)** | $**(13)** |
| **EBIT attributable to noncontrolling interests** | $**(3)** | $**(12)** | $**(6)** | $**(18)** |
| **Other income (expense) - net** | $**(11)** | $**(16)** | $**(21)** | $**(32)** |
| **Segment EBIT** | $**101** | $**185** | $**217** | $**411** |
| &nbsp;&nbsp;&nbsp;&nbsp;Mark-to-market timing differences | 15 | 8 | 22 | (14) |
| &nbsp;&nbsp;&nbsp;&nbsp;Certain (gains) & charges |  |  |  |  |
| **Adjusted Segment EBIT** | $**116** | $**193** | $**239** | $**397** |

---

**Refined & Specialty Oils Summary**

Results were down in all regions, but primarily driven by North America and Europe.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**Milling** 

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
|<br>**(US$ in millions)** | **Jun 30, 2025** | **Jun 30, 2024** | **Jun 30, 2025** | **Jun 30, 2024** |
| **Volumes (in thousand metric tons)** | **857** | **971** | **1755** | **1845** |
| **Net Sales** | $**409** | $**401** | $**784** | $**782** |
| **Gross Profit** | $**47** | $**66** | $**91** | $**126** |
| **Selling, general and administrative expense** | $**(24)** | $**(24)** | $**(47)** | $**(49)** |
| **Other income (expense) - net** | $**155** | $**(1)** | $**154** | $**(3)** |
| **Segment EBIT** | $**177** | $**38** | $**195** | $**71** |
| &nbsp;&nbsp;&nbsp;&nbsp;Mark-to-market timing differences | 5 | (10) | 2 | (15) |
| &nbsp;&nbsp;&nbsp;&nbsp;Certain (gains) & charges | (155) |  | (155) |  |
| **Adjusted Segment EBIT** | $**27** | $**28** | $**42** | $**56** |

---

**Milling Summary**

Higher results in North America were more than offset by lower results in South America.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**Corporate and Other**<sup>(6)</sup> 

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
|<br>**(US$ in millions)** | **Jun 30, 2025** | **Jun 30, 2024** | **Jun 30, 2025** | **Jun 30, 2024** |
| **Gross Profit** | $**(5)** | $**(6)** | $**8** | $**(3)** |
| **Selling, general and administrative expense** | $**(146)** | $**(175)** | $**(268)** | $**(334)** |
| **Foreign exchange gains (losses) – net** | $**14** | $**6** | $**16** | $**1** |
| **Other income (expense) - net** | $**15** | $**18** | $**46** | $**51** |
| **Income (loss) from affiliates** | $**—** | $**(20)** | $**—** | $**3** |
| **Corporate and Other EBIT** | $**(121)** | $**(176)** | $**(197)** | $**(280)** |
| &nbsp;&nbsp;&nbsp;&nbsp;Certain (gains) & charges | 38 | 62 | 70 | 123 |
| **Adjusted Corporate and Other EBIT** | $**(83)** | $**(114)** | $**(127)** | $**(157)** |

---

***Corporate***

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
|<br>**(US$ in millions)** | **Jun 30, 2025** | **Jun 30, 2024** | **Jun 30, 2025** | **Jun 30, 2024** |
| Corporate EBIT | $(120) | $(168) | $(207) | $(308) |
| &nbsp;&nbsp;&nbsp;&nbsp;Certain (gains) & charges | 38 | 62 | 70 | 123 |
| Adjusted Corporate EBIT | $(82) | $(106) | $(137) | $(185) |

---

***Other***

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
|<br>**(US$ in millions)** | **Jun 30, 2025** | **Jun 30, 2024** | **Jun 30, 2025** | **Jun 30, 2024** |
| Other EBIT | $(1) | $(8) | $10 | $28 |
| &nbsp;&nbsp;&nbsp;&nbsp;Certain (gains) & charges |  |  |  |  |
| Adjusted Other EBIT | $(1) | $(8) | $10 | $28 |

---

**Corporate and Other Summary**

The decrease in Corporate expenses was primarily driven by performance-based compensation. Prior year Other results include a loss of $21 million from the sugar & bioenergy joint venture that we divested in the fourth quarter of last year.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**Cash Flow**

---

| | | |
|:---|:---|:---|
| | **Six Months Ended** | **Six Months Ended** |
| | **Jun 30, 2025** | **Jun 30, 2024** |
| Cash provided by (used for) operating activities | $**(1357)** | $**(480)** |
| Certain reconciling items to Adjusted funds from operations <sup>(4)</sup> | **2050** | **1375** |
| Adjusted funds from operations <sup>(4)</sup> | $**693** | $**895** |

---

Cash used for operations in the six months ended June 30, 2025 and June 30, 2024 was $1,357 million and $480 million, respectively. The reduction of cash from operations was primarily driven by net changes in working capital. Adjusted funds from operations (FFO) was $693 million compared to $895 million in the prior year.<sup>(4)</sup>

**Income Taxes**

For the six months ended June 30, 2025, income tax expense was $204 million compared to $147 million in the prior year. The increase was primarily due to higher pre-tax income in 2025.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| ⮚ | **Outlook**<sup>(5)</sup> |

---

Taking into account second quarter results, the current margin and macro environment and forward curves, we continue to forecast full-year 2025 adjusted EPS of approximately $7.75, which no longer includes second half earnings from our corn milling business because of its sale which closed on June 30, 2025. This forecast excludes the impact of Viterra, which closed on July 2, 2025.

In Agribusiness, full-year results are forecasted to be higher than our previous outlook driven by Processing, but remain down from last year.

In Refined and Specialty Oils, full-year results are expected to be down from our previous outlook reflecting the softer second quarter performance and down from last year.

In Milling, full-year results are expected to be down from our previous outlook reflecting the sale of corn milling and in line with last year.

In Corporate and Other, full-year results are expected to be in line with our previous outlook and more favorable than last year.

Additionally, the Company expects the following for 2025: an adjusted annual effective tax rate in the range of 21% to 25%; net interest expense in the lower end of the range of $220 to $250 million; capital expenditures in the range of $1.5 to $1.7 billion; and depreciation and amortization of approximately $490 million.

We anticipate providing a forecast for the combined company prior to reporting third quarter earnings.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| ⮚ | **Conference Call and Webcast Details** |

---

Bunge Global SA's management will host a conference call at 8:00 a.m. Eastern (7:00 a.m. Central) on Wednesday, July 30, 2025 to discuss the Company's results.

Additionally, a slide presentation to accompany the discussion of results will be posted on <u>www.bunge.com</u>.

To access the webcast, go to "Events & Presentations" under "News & Events" in the "Investor Center" section of the company's website. Select "Q2 2025 Bunge Global SA Conference Call" and follow the prompts. Please go to the website at least 15 minutes prior to the call to register and download any necessary audio software.

To listen to the call, please dial 1-844-735-3666. If you are located outside the United States or Canada, dial 1-412-317-5706. Please dial in five to 10 minutes before the scheduled start time. The call will also be webcast live at <u>www.bunge.com</u>.

A call replay will be available later in the day on July 30, 2025, continuing through August 27, 2025. To access it, please dial 1-877-344-7529 in the United States, 1-855-669-9658 in Canada, or 1-412-317-0088 in other locations. When prompted, enter confirmation code 9672348.

---

| | |
|:---|:---|
| ⮚ | **About Bunge** |

---

At Bunge (NYSE: BG), our purpose is to connect farmers to consumers to deliver essential food, feed and fuel to the world. As a premier agribusiness solutions provider, our team of ~37,000 dedicated employees partner with farmers across the globe to move agricultural commodities from where they're grown to where they're needed—in faster, smarter, and more efficient ways. We are a world leader in grain origination, storage, distribution, oilseed processing and refining, offering a broad portfolio of plant-based oils, fats, and proteins. We work alongside our customers at both ends of the value chain to deliver quality products and develop tailored, innovative solutions that address evolving consumer needs. With 200+ years of experience and presence in over 50 countries, we are committed to strengthening global food security, advancing sustainability, and helping communities prosper where we operate. Bunge has its registered office in Geneva, Switzerland and its corporate headquarters in St. Louis, Missouri. Learn more at Bunge.com.

---

| | |
|:---|:---|
| ⮚ | **Website Information** |

---

We routinely post important information for investors on our website, <u>[www.bunge.com](#i5bc7ce0b5c5a4182aa6a66dbc27e1570_4)</u>, in the "Investors" section. We may use this website as a means of disclosing material, non-public information and for complying with our disclosure obligations under Regulation FD. Accordingly, investors should monitor the Investors section of our website, in addition to following our press releases, U.S. Securities and Exchange Commission ("SEC") filings, public conference calls, presentations and webcasts. The information contained on, or that may be accessed through, our website is not incorporated by reference into, and is not a part of, this document.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| ⮚ | **Cautionary Statement Concerning Forward Looking Statements** |

---

The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward looking statements to encourage companies to provide prospective information to investors. This press release includes forward looking statements that reflect our current expectations and projections about our future results, performance, prospects and opportunities. Forward looking statements include all statements that are not historical in nature. We have tried to identify these forward looking statements by using words including "may," "will," "should," "could," "expect," "anticipate," "believe," "plan," "intend," "estimate," "continue" and similar expressions. These forward looking statements are subject to a number of risks, uncertainties, assumptions and other factors that could cause our actual results, performance, prospects or opportunities to differ materially from those expressed in, or implied by, these forward looking statements. The following factors, among others, could cause actual results to differ from these forward looking statements:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the impact on our employees, operations, and facilities from the war in Ukraine and the resulting economic and other sanctions imposed on Russia, including the impact on us resulting from the continuation and/or escalation of the war and sanctions against Russia;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the effect of weather conditions and the impact of crop and animal disease on our business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the impact of global and regional economic, agricultural, financial and commodities market, political, social and health conditions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes in government policies and laws affecting our business, including agricultural and trade (including tariff) policies, financial markets regulation and environmental, tax and biofuels regulation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the impact of seasonality;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the impact of government policies and regulations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the outcome of pending regulatory and legal proceedings;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to complete, integrate and benefit from acquisitions, divestitures, joint ventures and strategic alliances, including without limitation Bunge's business combination with Viterra Limited ("Viterra");

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the impact of industry conditions, including fluctuations in supply, demand and prices for agricultural commodities and other raw materials and products that we sell and use in our business, fluctuations in energy and freight costs and competitive developments in our industries;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the effectiveness of our capital allocation plans, funding needs and financing sources;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the effectiveness of our risk management strategies;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• operational risks, including industrial accidents, natural disasters, pandemics or epidemics, wars and cybersecurity incidents;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes in foreign exchange policy or rates;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the impact of our dependence on third parties;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to attract and retain executive management and key personnel; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• other factors affecting our business generally.

The forward looking statements included in this release are made only as of the date of this release, and except as otherwise required by federal securities law, we do not have any obligation to publicly update or revise any forward looking statements to reflect subsequent events or circumstances.

You should refer to "Item 1A. Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on February 20, 2025.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;**Investor Contact:**<br>Mark Haden<br>Bunge Global SA<br>Mark.Haden@bunge.com | &nbsp;&nbsp;&nbsp;**Media Contact:**<br>Bunge News Bureau<br>Bunge Global SA<br>636-292-3022<br>news@bunge.com |

---

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| ⮚ | **Additional Financial Information** |

---

**Certain gains and (charges), quarter-to-date**

The following table provides a summary of certain gains and (charges) that may be of interest to investors, including a description of these items and their effect on Net income (loss) attributable to Bunge, Earnings per share diluted and EBIT for the three month periods ended June 30, 2025 and 2024.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **(US$ in millions, except per share data)** | **Net Income (Loss)<br>Attributable to<br>Bunge** | **Net Income (Loss)<br>Attributable to<br>Bunge** | **Earnings<br>Per Share<br>Diluted** | **Earnings<br>Per Share<br>Diluted** | **<br>EBIT** | **<br>EBIT** |
| **Three months ended June 30,** | **2025** | **2024** | **2025** | **2024** | **2025** | **2024** |
| **Reportable Segments:** | $**118** | $**—** | $**0.87** | $**—** | $**155** | $**—** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Agribusiness** | $**—** | $**—** | $**—** | $**—** | $**—** | $**—** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Refined and Specialty Oils** | $**—** | $**—** | $**—** | $**—** | $**—** | $**—** |
| &nbsp;&nbsp;&nbsp;&nbsp;**RCF** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;**Milling** | $**118** | $**—** | $**0.87** | $— | $**155** | $**—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on sale of a business | 118 |  | 0.87 |  | 155 |  |
| **Corporate and Other:**  | $**(36)** | $**(62)** | $**(0.26)** | $**(0.43)** | $**(38)** | $**(62)** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisition and integration costs | (36) | (62) | (0.26) | (0.43) | (38) | (62) |
| **Total** | $**82** | $**(62)** | $**0.61** | $**(0.43)** | $**117** | $**(62)** |

---

See Definition and Reconciliation of Non-GAAP Measures.

**Reportable Segments**

**Milling**

EBIT for the three months ended June 30, 2025 included a $155 million gain on sale from the disposition of our corn milling business in North America, recorded in Other income (expense) - net.

**Corporate and Other** 

The following is a summary of acquisition and integration costs related to the consummated business combination with Viterra recorded in the Company's Condensed Consolidated Statements of Income (Loss).

---

| | | |
|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** |
|<br>**(US$ in millions)** | **Jun 30, 2025** | **Jun 30, 2024** |
| Cost of goods sold | $(3) | $— |
| Selling, general and administrative expenses | (35) | (62) |
| Interest expense | (3) | (4) |
| Income tax (expense) benefit | 5 | 4 |
| **Net income (loss)** | $**(36)** | $**(62)** |

---

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**Certain gains and (charges), year-to-date**

The following table provides a summary of certain gains and (charges) that may be of interest to investors, including a description of these items and their effect on Net income (loss) attributable to Bunge, Earnings per share diluted and EBIT for the six month periods ended June 30, 2025 and 2024.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **(US$ in millions, except per share data)** | **Net Income (Loss)<br>Attributable to<br>Bunge** | **Net Income (Loss)<br>Attributable to<br>Bunge** | **Earnings<br>Per Share<br>Diluted** | **Earnings<br>Per Share<br>Diluted** | **EBIT** | **EBIT** |
| **Six months ended June 30,** | **2025** | **2024** | **2025** | **2024** | **2025** | **2024** |
| **Reportable Segments:** | $**118** | $**—** | $**0.87** | $**—** | $**155** | $**—** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Agribusiness** | $**—** | $**—** | $**—** | $**—** | $**—** | $**—** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Refined and Specialty Oils** | $**—** | $**—** | $**—** | $**—** | $**—** | $**—** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Milling** | $**118** | $**—** | $**0.87** | $**—** | $**155** | $**—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on sale of a business | 118 |  | 0.87 |  | 155 |  |
| **Corporate and Other:**  | $**(69)** | $**(123)** | $**(0.51)** | $**(0.85)** | $**(70)** | $**(123)** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisition and integration costs | (69) | (123) | (0.51) | (0.85) | (70) | (123) |
| **Total** | $**49** | $**(123)** | $**0.36** | $**(0.85)** | $**85** | $**(123)** |

---

See Definition and Reconciliation of Non-GAAP Measures.

**Reportable Segments**

**Milling**

EBIT for the six months ended June 30, 2025 included a $155 million gain on sale from the disposition of our corn milling business in North America, recorded in Other income (expense) - net.

**Corporate and Other**

The following is a summary of acquisition and integration costs related to the consummated business combination with Viterra recorded in the Company's Condensed Consolidated Statements of Income (Loss).

---

| | | |
|:---|:---|:---|
| | **Six Months Ended** | **Six Months Ended** |
|<br>**(US$ in millions)** | **Jun 30, 2025** | **Jun 30, 2024** |
| Cost of goods sold | $(3) | $— |
| Selling, general and administrative expenses | (67) | (123) |
| Interest expense | (7) | (8) |
| Income tax (expense) benefit | 8 | 8 |
| **Net income (loss)** | $**(69)** | $**(123)** |

---

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| ⮚ | **Condensed Consolidated Earnings Data (Unaudited)** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>June 30,** | **Three Months Ended<br>June 30,** | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** |
|<br>**(US$ in millions, except per share data)** | **2025** | **2024** | **2025** | **2024** |
| Net sales | $12769 | $13241 | $24412 | $26658 |
| Cost of goods sold | (12031) | (12577) | (23077) | (25118) |
| **Gross profit** | **738** | **664** | **1335** | **1540** |
| Selling, general and administrative expenses | (418) | (449) | (798) | (888) |
| Foreign exchange gains (losses) – net | 44 | (37) | 69 | (115) |
| Other income (expense) – net | 187 | 57 | 269 | 125 |
| Income (loss) from affiliates | 3 | (46) | 8 | (38) |
| EBIT attributable to noncontrolling interest <sup>(a) (1)</sup> | (16) | (4) | (17) | (6) |
| **Total EBIT** | **538** | **185** | **866** | **618** |
| Interest income | 46 | 37 | 105 | 79 |
| Interest expense | (106) | (123) | (210) | (231) |
| Income tax (expense) benefit | (124) | (30) | (204) | (147) |
| Noncontrolling interest share of interest and tax <sup>(a) (1)</sup> |  | 1 | (2) | (5) |
| **Net income (loss) attributable to Bunge** <sup>(1)</sup> | $**354** | $**70** | $**555** | $**314** |
| **Net income (loss) attributable to Bunge shareholders - diluted** | $**2.61** | $**0.48** | $**4.10** | $**2.17** |
| **Weighted–average shares outstanding - diluted** | **136** | **143** | **135** | **144** |

---

*(a) The line items "EBIT attributable to noncontrolling interest" and "Noncontrolling interest share of interest and tax" when combined, represent consolidated Net (income) loss attributable to noncontrolling interests and redeemable noncontrolling interests on a U.S. GAAP basis of presentation.*

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| ⮚ | **Condensed Consolidated Balance Sheets (Unaudited)** |

---

---

| | | |
|:---|:---|:---|
|<br>**(US$ in millions)** | **June 30,**<br>**2025** | **December 31,**<br>**2024** |
| **Assets** |  |  |
| Cash and cash equivalents | $6790 | $3311 |
| Trade accounts receivable, net | 2258 | 2148 |
| Inventories <sup>(a)</sup> | 8014 | 6491 |
| Assets held for sale | 178 | 8 |
| Other current assets | 4205 | 4000 |
| **Total current assets** | **21445** | **15958** |
| Property, plant and equipment, net | 5828 | 5254 |
| Operating lease assets | 1002 | 932 |
| Goodwill and other intangible assets, net | 776 | 774 |
| Investments in affiliates | 862 | 779 |
| Other non-current assets | 1241 | 1202 |
| **Total assets** | $**31154** | $**24899** |
| **Liabilities and Equity** |  |  |
| Short-term debt | $3535 | $875 |
| Current portion of long-term debt | 690 | 669 |
| Trade accounts payable | 2894 | 2777 |
| Current operating lease obligations | 282 | 286 |
| Liabilities held for sale | 67 | 10 |
| Other current liabilities | 2916 | 2818 |
| **Total current liabilities** | **10384** | **7435** |
| Long-term debt | 7044 | 4694 |
| Non-current operating lease obligations | 662 | 595 |
| Other non-current liabilities | 1108 | 1226 |
| **Total liabilities** | **19198** | **13950** |
| **Redeemable noncontrolling interest** | **61** | **4** |
| **Total equity** | **11895** | **10945** |
| **Total liabilities, redeemable noncontrolling interest and equity** | $**31154** | $**24899** |

---

*(a) Includes RMI of $6,657 million and $5,224 million at June 30, 2025 and December 31, 2024, respectively.*

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| ⮚ | **Condensed Consolidated Statements of Cash Flows (Unaudited)** |

---

---

| | | |
|:---|:---|:---|
| | **Six Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** |
|<br>**(US$ in millions)** | **2025** | **2024** |
| **Operating Activities** |  |  |
| Net income (loss) <sup>(1)</sup> | $574 | $325 |
| Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign exchange (gain) loss on net debt | (208) | 103 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation, depletion and amortization | 236 | 226 |
| &nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation expense | 35 | 34 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred income tax expense (benefit) | 20 | (27) |
| &nbsp;&nbsp;&nbsp;(Gain) loss on sale of investments and property, plant and equipment | (148) | (1) |
| &nbsp;&nbsp;&nbsp;&nbsp;Results from affiliates | (8) | 38 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other, net | 87 | 59 |
| Changes in operating assets and liabilities, excluding the effects of acquisitions and dispositions: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Trade accounts receivable | (110) | 173 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories | (1261) | (1273) |
| &nbsp;&nbsp;&nbsp;&nbsp;Secured advances to suppliers | (254) | 88 |
| &nbsp;&nbsp;&nbsp;&nbsp;Trade accounts payable and accrued liabilities | (55) | (147) |
| &nbsp;&nbsp;&nbsp;&nbsp;Advances on sales | (107) | (90) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net unrealized (gain) loss on derivative contracts | (120) | 329 |
| &nbsp;&nbsp;&nbsp;&nbsp;Margin deposits | (59) | (315) |
| &nbsp;&nbsp;&nbsp;&nbsp;Recoverable and income taxes, net | 71 | (149) |
| &nbsp;&nbsp;&nbsp;&nbsp;Marketable securities | 16 | (21) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other, net | (66) | 168 |
| &nbsp;&nbsp;&nbsp;**&nbsp;&nbsp;&nbsp;&nbsp;Cash provided by (used for) operating activities** | **(1357)** | **(480)** |
| **Investing Activities** |  |  |
| Payments made for capital expenditures | (716) | (533) |
| Proceeds from investments | 850 | 554 |
| Payments for investments | (783) | (638) |
| Settlement of net investment hedges | (27) | (1) |
| Proceeds from disposal of business and property, plant and equipment | 472 | 3 |
| Proceeds from sale of investments in affiliates | 100 | 103 |
| Payments for investments in affiliates | (63) | (18) |
| Other, net | 65 | (18) |
| &nbsp;&nbsp;&nbsp;**&nbsp;&nbsp;&nbsp;&nbsp;Cash provided by (used for) investing activities** | **(102)** | **(548)** |
| **Financing Activities** |  |  |
| Net borrowings (repayments) of short-term debt | 2664 | 177 |
| Net proceeds (repayments) of long-term debt | 2246 | 14 |
| Repurchases of registered or common shares |  | (400) |
| Dividends paid to registered or common shareholders | (185) | (191) |
| Contributions from (Return of capital to) noncontrolling interest | 30 | 31 |
| Sale of redeemable noncontrolling interest | 206 |  |
| Acquisition of noncontrolling interest | (18) |  |
| Other, net | (5) | (19) |
| &nbsp;&nbsp;&nbsp;**&nbsp;&nbsp;&nbsp;&nbsp;Cash provided by (used for) financing activities** | **4938** | **(388)** |
| **Effect of exchange rate changes on cash and cash equivalents, and restricted cash** | **5** | **(6)** |
| **Net increase (decrease) in cash and cash equivalents, and restricted cash** | **3484** | **(1422)** |
| **Cash and cash equivalents, and restricted cash - beginning of period** | **3328** | **2623** |
| **Cash and cash equivalents, and restricted cash - end of period** | $**6812** | $**1201** |

---

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| ⮚ | **Definition and Reconciliation of Non-GAAP Measures** |

---

This earnings release contains certain "non-GAAP financial measures" as defined in Regulation G of the Securities Exchange Act of 1934. Bunge has reconciled these non-GAAP financial measures to the most directly comparable U.S. GAAP measures below. These measures may not be comparable to similarly titled measures used by other companies.

**Total EBIT and Adjusted Total EBIT**

Bunge uses earnings before interest and tax ("EBIT") to evaluate the operating performance of its individual reportable segments as well as Corporate and Other results. Total EBIT excludes EBIT attributable to noncontrolling interests. Bunge also uses Segment EBIT, Corporate and Other EBIT and Total EBIT to evaluate the operating performance of Bunge's reportable segments and Total reportable segments together with Corporate and Other activities. Segment EBIT is the aggregate of the earnings before interest and taxes of each of Bunge's Agribusiness, Refined and Specialty Oils, and Milling segments. Total EBIT is the aggregate of the earnings before interest and taxes of Bunge's reportable segments, together with its Corporate and Other activities.

Adjusted Segment EBIT, Adjusted Corporate and Other EBIT and Adjusted Total EBIT, are calculated by excluding temporary mark-to-market timing differences, as defined in note 3 below, and certain gains and (charges), as described in "Additional Financial Information" above, from Segment EBIT, Corporate and Other EBIT, and Total EBIT, respectively.

Segment EBIT, Corporate and Other EBIT, Total EBIT, Adjusted Segment EBIT, Adjusted Corporate and Other EBIT, and Adjusted Total EBIT are non-GAAP financial measures and are not intended to replace Net income (loss) attributable to Bunge, the most directly comparable U.S. GAAP financial measure. Bunge's management believes these non-GAAP measures are a useful measure of its operating profitability, since the measures allow for an evaluation of performance without regard to financing methods or capital structure. For this reason, operating performance measures such as these non-GAAP measures are widely used by analysts and investors in Bunge's industries. These non-GAAP measures are not a measure of consolidated operating results under U.S. GAAP and should not be considered as an alternative to Net income (loss) or any other measure of consolidated operating results under U.S. GAAP.

**Net Income (loss) attributable to Bunge to Adjusted Net Income (loss) attributable to Bunge**

Adjusted Net Income (loss) excludes temporary mark-to-market timing differences, as defined in note 3 below, and certain gains and (charges), as described in "Additional Financial Information" above, and is a non-GAAP financial measure. This measure is not a measure of Net income (loss) attributable to Bunge, the most directly comparable U.S. GAAP financial measure. It should not be considered as an alternative to Net Income (loss) attributable to Bunge, Net Income (loss), or any other measure of consolidated operating results under U.S. GAAP. Bunge's management believes Adjusted Net income (loss) is a useful measure of the Company's profitability.

We also have presented projected Adjusted Net income per share for 2025. This information is provided only on a non-GAAP basis without reconciliation to projected Net Income per share for 2025, the most directly comparable U.S. GAAP measure. The most directly comparable GAAP measure has not been provided due to the inability to quantify certain amounts necessary for such reconciliation, including but not limited to potentially significant future market price movements over the remainder of the year.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Below is a reconciliation of Net income (loss) attributable to Bunge, to Total EBIT, and Adjusted Total EBIT:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>June 30,** | **Three Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** |
|<br>**(US$ in millions)** | **2025** | **2024** | **2025** | **2024** |
| &nbsp;&nbsp;&nbsp;**Net income (loss) attributable to Bunge** | $354 | $70 | $555 | $314 |
| &nbsp;&nbsp;&nbsp;Interest income | (46) | (37) | (105) | (79) |
| &nbsp;&nbsp;&nbsp;Interest expense | 106 | 123 | 210 | 231 |
| &nbsp;&nbsp;&nbsp;Income tax expense (benefit) | 124 | 30 | 204 | 147 |
| &nbsp;&nbsp;&nbsp;Noncontrolling interest share of interest and tax |  | (1) | 2 | 5 |
| &nbsp;&nbsp;&nbsp;**Total EBIT** | $**538** | $**185** | $**866** | $**618** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Agribusiness EBIT | $381 | $138 | $651 | $416 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Refined and Specialty Oils EBIT | 101 | 185 | 217 | 411 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Milling EBIT | 177 | 38 | 195 | 71 |
| &nbsp;&nbsp;&nbsp;**Segment EBIT** | $**659** | $**361** | $**1063** | $**898** |
| &nbsp;&nbsp;**Corporate and Other EBIT**<sup>(6)</sup> | $**(121)** | $**(176)** | $**(197)** | $**(280)** |
| &nbsp;&nbsp;&nbsp;**Total EBIT** | $**538** | $**185** | $**866** | $**618** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mark-to-market timing difference | (128) | 158 | (126) | 340 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Certain (gains) & charges | (117) | 62 | (85) | 123 |
| &nbsp;&nbsp;&nbsp;**Adjusted Total EBIT** | $**293** | $**405** | $**655** | $**1081** |

---

Below is a reconciliation of Net income (loss) attributable to Bunge, to Adjusted Net income (loss) attributable to Bunge:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>June 30,** | **Three Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** |
|<br>**(US$ in millions, except per share data)** | **2025** | **2024** | **2025** | **2024** |
| **Net income (loss) attributable to Bunge** | $**354** | $70 | $**555** | $314 |
| Adjustment for Mark-to-market timing difference | (94) | 116 | (84) | 252 |
| Adjusted for Certain (gains) and charges: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain on sale of a business | (118) |  | (118) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition and integration costs | 36 | 62 | 69 | 123 |
| **Adjusted Net income (loss) attributable to Bunge** | $**178** | $248 | $**422** | $689 |
| Weighted-average shares outstanding - diluted <sup>(a)</sup> | 136 | 143 | 135 | 144 |
| **Adjusted Net income (loss) per share - diluted** | $**1.31** | $1.73 | $**3.12** | $4.77 |

---

*(a) There were less than 1 million anti-dilutive outstanding stock options or contingently issuable restricted stock units excluded from the weighted-average number of shares outstanding for each of the three and six months ended June 30, 2025 and 2024.*

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**Adjusted Funds From Operations**

Adjusted FFO is calculated by excluding from Cash provided by (used for) operating activities, foreign exchange gain (loss) on net debt, working capital changes, net (income) loss attributable to noncontrolling interests and redeemable noncontrolling interests, and mark-to-market timing differences after tax. Adjusted FFO is a non-GAAP financial measure and is not intended to replace Cash provided by (used for) operating activities, the most directly comparable U.S. GAAP financial measure. Bunge's management believes the presentation of this measure allows investors to view its cash generating performance using the same measure that management uses in evaluating financial and business performance and trends without regard to foreign exchange gains and losses, working capital changes and mark-to-market timing differences. This non-GAAP measure is not a measure of consolidated cash flow under U.S. GAAP and should not be considered as an alternative to Cash provided by (used for) operating activities, Net increase (decrease) in cash and cash equivalents, and restricted cash, or any other measure of consolidated cash flow under U.S. GAAP.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| ⮚ | **Notes** |

---

(1)&nbsp;&nbsp;&nbsp;&nbsp;A reconciliation of Net income (loss) attributable to Bunge, to Net income (loss) is as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended June 30,** | **Three months ended June 30,** | **Six months ended June 30,** | **Six months ended June 30,** |
|<br>**(US$ in millions)** | **2025** | **2024** | **2025** | **2024** |
| Net income (loss) attributable to Bunge | $354 | $70 | $555 | $314 |
| EBIT attributable to noncontrolling interest | 16 | 4 | 17 | 6 |
| Noncontrolling interest share of interest and tax |  | (1) | 2 | 5 |
| **Net income (loss)** | $**370** | $**73** | $**574** | $**325** |

---

(2)&nbsp;&nbsp;&nbsp;&nbsp;The Processing business included in our Agribusiness segment consists of: global oilseed processing activities, which principally include the origination and crushing of oilseeds (including soybeans, canola, rapeseed and sunflower seed) into protein meals and vegetable oils; the distribution of oilseeds, oilseed products and fertilizer products through our port terminals and transportation assets (including trucks, railcars, barges and ocean vessels); fertilizer production; and biodiesel production, which is partially conducted through joint ventures.

The Merchandising business included in our Agribusiness segment primarily consists of: global grain origination activities, which principally include the purchasing, cleaning, drying, storing and handling of corn, wheat and barley at our network of grain elevators; global trading and distribution of grains and oils; logistical services for the distribution of these commodities to our customer markets through our port terminals and transportation assets (including trucks, railcars, barges and ocean vessels); and financial services and activities for customers from whom we purchase commodities, and other third parties.

(3)&nbsp;&nbsp;&nbsp;&nbsp;Mark-to-market timing difference comprises the estimated net temporary impact resulting from unrealized period-end gains/losses associated with the fair valuation of certain forward contracts, RMI, and related futures contracts associated with our committed future operating capacity and sales. The impact of these mark-to-market timing differences, which is expected to reverse over time due to the forward contracts, RMI, and related futures contracts being part of an economically-hedged position, is not representative of the operating performance of our business.

(4)&nbsp;&nbsp;&nbsp;&nbsp;A reconciliation of Cash provided by (used for) operating activities to Adjusted funds from operations (FFO) is as follows:

---

| | | |
|:---|:---|:---|
| | **Six months ended June 30,** | **Six months ended June 30,** |
|<br>**(US$ in millions)** | **2025** | **2024** |
| Cash provided by (used for) operating activities | $(1357) | $(480) |
| Foreign exchange gain (loss) on net debt | 208 | (103) |
| Working capital changes | 1945 | 1237 |
| Net (income) loss attributable to noncontrolling interests and redeemable noncontrolling interests | (19) | (11) |
| Mark-to-Market timing difference, after tax | (84) | 252 |
| **Adjusted FFO** | $**693** | $**895** |

---

(5)&nbsp;&nbsp;&nbsp;&nbsp;We have not presented a comparable U.S. GAAP financial measure for any full-year 2025 outlook financial measures presented on an adjusted, non-GAAP basis because the information necessary for such presentation is unavailable at this time. The information necessary to prepare the comparable U.S. GAAP presentation could result in significant differences from the non-GAAP financial measures presented in this release. Please see "Definition and Reconciliation of Non-GAAP Measures" for more information.

(6)&nbsp;&nbsp;&nbsp;&nbsp;Effective January 1, 2025, Bunge's Sugar & Bioenergy segment reporting activity has been reclassified to Corporate and Other. Historically, the Sugar & Bioenergy segment was primarily comprised of our previously owned 50% interest in the BP Bunge Bioenergia joint venture, which was divested in the fourth quarter of 2024. Following the divestment, Bunge no longer separately presents a Sugar & Bioenergy segment as the remaining activity is insignificant, nor separately present segment results between Core segment and Non-core segment. Corresponding prior period amounts have been restated to conform to current period presentation. This change has no impact on previously-reported condensed consolidated earnings data, condensed consolidated balance sheets, or condensed consolidated statements of cash flows.